ImmunoGen, Inc. (IMGN) Announces Webcast of Presentation at the Oppenheimer 23rd Annual Healthcare Conference
12/6/2012 11:37:52 AM
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Daniel Junius, President and CEO, will present at the upcoming Oppenheimer 23rd Annual Healthcare Conference in New York. The presentation is scheduled for 10:00 am ET on December 13, 2012. The webcast of this presentation can be accessed live through the “Investor Information” section of the Company’s website, www.immunogen.com; a replay of the presentation will be available at the same location for one week.